Hong Kunxue相关文献与解析，生知库 | 链接生命科学的每一步

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

重组双组分SARS-CoV-2蛋白疫苗的安全性和免疫原性：随机、双盲、安慰剂对照的I期和II期研究

Wynne, Chris; Balgos, Abundio; Li, Jingxin; Hamilton, Paul; Tirador, Louie; Jaen, Anjuli May; Mo, Chen; Yue, Zijing; Ma, Ying; Wang, Qingshuang; Wen, Rendu; Yao, Zheng; Yu, Jiaping; Yao, Wenrong; Zhang, Jianhui; Zheng, Hui; Hong, Kunxue; Zhu, Fengcai; Liu, Yong

SARS-CoV-2

免疫/内分泌

发表日期：2024

文献求助收藏

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

更正：重组双组分SARS-CoV-2蛋白疫苗的安全性和免疫原性：随机、双盲、安慰剂对照的I期和II期研究

期刊:Infectious Diseases and Therapy

影响因子:5.3

doi:10.1007/s40121-024-00998-z

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19

脂肽类HIV融合抑制剂LP-19具有广谱抗HIV活性和高耐药屏障

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2023.1199938

He, Lin; Wang, Chen; Zhang, Yuanyuan; Chong, Huihui; Hu, Xiaoyan; Li, Dan; Xing, Hui; He, Yuxian; Shao, Yiming; Hong, Kunxue; Ma, Liying

Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time

来自未经治疗患者的 HIV-1 CRF07_BC 的中和敏感性及其随时间的变化

期刊:Frontiers in Cellular and Infection Microbiology

影响因子:4.8

doi:10.3389/fcimb.2022.862754

Wang, Lijie; Liang, Shujia; Huang, Jianhua; Ding, Yibo; He, Lin; Hao, Yanling; Ren, Li; Zhu, Meiling; Feng, Yi; Rashid, Abdur; Liu, Yue; Jiang, Shibo; Hong, Kunxue; Ma, Liying

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy - China, 2018-2019

2018-2019年中国HIV治疗前耐药性对一年抗逆转录病毒治疗后病毒学失败的影响

期刊:China CDC Weekly

影响因子:2.9

doi:10.46234/ccdcw2022.116

Li, Miaomiao; Song, Chang; Dong, Aobo; Hu, Jing; Kang, Ruihua; Xing, Hui; Ruan, Yuhua; Shao, Yiming; Hong, Kunxue; Liao, Lingjie

Premature Stop Codon at Residue 101 within HIV-1 Rev Does Not Influence Viral Replication of Clade BC but Severely Reduces Viral Fitness of Clade B

HIV-1 Rev蛋白第101位氨基酸残基的提前终止密码子不影响BC亚型病毒的复制，但会严重降低B亚型病毒的适应性。

期刊:Virologica Sinica

影响因子:4

doi:10.1007/s12250-019-00179-0

Wang, Zheng; Ji, Xiaolin; Hao, Yanling; Hong, Kunxue; Ma, Liying; Li, Dan; Shao, Yiming

MicroRNA 31 inhibits CD8(+) T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection

在慢性病毒感染中，microRNA 31 通过增加 CD8(+) T 细胞对 I 型干扰素信号的敏感性来抑制其功能。

期刊:Cellular & Molecular Immunology

影响因子:19.8

doi:10.1038/cmi.2017.99

Jia, Mingming; Shao, Yiming; Hong, Kunxue

Construction and characterization of highly infectious full-length molecular clones of a HIV-1 CRF07_BC isolate from Xinjiang, China

构建和鉴定来自中国新疆的HIV-1 CRF07_BC分离株的高传染性全长分子克隆

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0079177

Wang, Zheng; Hong, Kunxue; Zhang, Jing; Zhang, Lei; Li, Dan; Ren, Li; Liang, Hua; Shao, Yiming

Near full-length genome identification of a novel HIV type 1 B'/C recombinant isolate JL100091 in Jilin, China

中国吉林省分离出一种新型HIV 1型B'/C重组分离株JL100091，并对其进行了近乎全长的基因组鉴定。

期刊:Aids Research and Human Retroviruses

影响因子:1.1

doi:10.1089/aid.2013.0134

Ning, Chuanyi; Li, Xingguang; He, Xiang; Xing, Hui; Hong, Kunxue; Yang, Rongge; Shao, Yiming

Multiple Mechanisms of HIV-1 Resistance to PGT135 in a Chinese Subtype B' Slow Progressor

中国B'亚型慢进展型HIV-1对PGT135产生耐药性的多种机制

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

重组双组分SARS-CoV-2蛋白疫苗的安全性和免疫原性：随机、双盲、安慰剂对照的I期和II期研究

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

更正：重组双组分SARS-CoV-2蛋白疫苗的安全性和免疫原性：随机、双盲、安慰剂对照的I期和II期研究

Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19

脂肽类HIV融合抑制剂LP-19具有广谱抗HIV活性和高耐药屏障

Neutralization Sensitivity of HIV-1 CRF07_BC From an Untreated Patient With a Focus on Evolution Over Time

来自未经治疗患者的 HIV-1 CRF07_BC 的中和敏感性及其随时间的变化

Impact of HIV Pretreatment Drug Resistance on Virological Failure After One-Year Antiretroviral Therapy - China, 2018-2019

2018-2019年中国HIV治疗前耐药性对一年抗逆转录病毒治疗后病毒学失败的影响

Premature Stop Codon at Residue 101 within HIV-1 Rev Does Not Influence Viral Replication of Clade BC but Severely Reduces Viral Fitness of Clade B

HIV-1 Rev蛋白第101位氨基酸残基的提前终止密码子不影响BC亚型病毒的复制，但会严重降低B亚型病毒的适应性。

MicroRNA 31 inhibits CD8(+) T-cell function by increasing its sensitivity to type I interferon signaling in chronic viral infection

在慢性病毒感染中，microRNA 31 通过增加 CD8(+) T 细胞对 I 型干扰素信号的敏感性来抑制其功能。

Construction and characterization of highly infectious full-length molecular clones of a HIV-1 CRF07_BC isolate from Xinjiang, China

构建和鉴定来自中国新疆的HIV-1 CRF07_BC分离株的高传染性全长分子克隆

Near full-length genome identification of a novel HIV type 1 B'/C recombinant isolate JL100091 in Jilin, China

中国吉林省分离出一种新型HIV 1型B'/C重组分离株JL100091，并对其进行了近乎全长的基因组鉴定。